Primary information |
---|
ID | antitb_1867 |
Peptide Name | Anoplin |
Sequence | GLLKFIKKLL |
N-terminal Modification | Addition of decanoic acid (C10H20O2) |
C-terminal Modification | Amidation |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Length | 10 |
Chirality | L |
Nature | Amphipathic |
Source | Synthetic |
Origin | Anlogue of Anoplin |
Species | Mycobacterium smegmatis |
Strain | Mycobacterium smegmatis mc2 162 |
Inhibition Concentartion | MIC = 5 μg/mL |
In vitro/In vivo | In vitro |
Cell Line | RBC |
Inhibition Concentartion | NA |
Cytotoxicity | Non toxic to erythrocytes |
In vivo Model | NA |
Lethal Dose | NA |
Immune Response | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other Activities | Antifungal (C. parapsilosis) and Antibacterial (Escherichia coli DH5a, Pseudomonas aeruginosa PAO, and Zymomonas mobilis ATCC 10988; Gram-positive bacteria: Bacillus subtilis DELTA) |
Pubmed ID | 27862650 |
Year of Publication | 2016 |
3-D Structure | NA |